Medicis Pharmaceutical Corp (NYSE:MRX)

CAPS Rating: 5 out of 5

A specialty pharmaceutical company focused on the development and marketing of products in the United States for the treatment of dermatological, aesthetic and podiatric conditions.

Recs

0
Player Avatar 1badbeerad (40.18) Submitted: 11/25/2012 11:38:49 AM : Outperform Start Price: $43.26 MRX Score: -3.91

I'm so pretty and witty and wise.

Featured Broker Partners


Advertisement